Literature DB >> 17332954

Development of a perfused ex vivo tumor-mimic model for the training of laparoscopic radiofrequency ablation.

Philipp Hildebrand1, Markus Kleemann, Uwe Roblick, Lutz Mirow, Hans-Peter Bruch, C Bürk.   

Abstract

BACKGROUND: Laparoscopic radiofrequency ablation (RFA) is a safe and effective method for tumor destruction in patients with unresectable liver tumors. However, accurate probe placement using laparoscopic ultrasound guidance is required to achieve complete tumor ablation. This study aimed to develop a perfusable ex vivo tumor-mimic model for laparoscopic radiofrequency ablation training.
METHODS: After rinsing the prepared liver vessels with anticoagulants, porcine livers were perfused. Tumor-mimics were created by injecting a mixture consisting of 3% agarose, 3% cellulose, 7% glycerol, and 0.05% methylene blue, creating hyperechoic lesions in ultrasound. Heparinized porcine blood was used as perfusion medium. Continuous perfusion of the porcine liver was provided by connection of a pump system to the portal vein and the vena cava inferior. Laparoscopic RFA techniques were taught using a laparoscopic pelvi-trainer.
RESULTS: A total of 30 laparoscopic ablations were performed in four porcine livers. The simulated "tumors" were clearly visible on laparoscopic ultrasound and not felt during placement of the RFA probe. In addition, color duplex ultrasound showed clear signals indicating for a sufficient liver perfusion.
CONCLUSION: Laparoscopic RFA requires advanced laparoscopic ultrasound skills for an accurate placement of the RFA probe. The perfused tumor-mimic model presented is a safe, easy, effective, and economic method to improve and train laparoscopic RFA skills on porcine liver tissue.

Entities:  

Mesh:

Year:  2007        PMID: 17332954     DOI: 10.1007/s00464-007-9216-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  12 in total

1.  Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation.

Authors:  D J Scott; W N Young; L M Watumull; G Lindberg; J B Fleming; J F Huth; R V Rege; D R Jeyarajah; D B Jones
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

2.  Development of an in vivo tumor-mimic model for learning radiofrequency ablation.

Authors:  M D Scott DJ; W N Young; L M Watumull; G Lindberg; J B Fleming; R V Rege; R J Brown; D B Jones
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

Review 3.  Statistical assessment of the learning curves of health technologies.

Authors:  C R Ramsay; A M Grant; S A Wallace; P H Garthwaite; A F Monk; I T Russell
Journal:  Health Technol Assess       Date:  2001       Impact factor: 4.014

Review 4.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 5.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

6.  Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.

Authors:  A E Siperstein; S J Rogers; P D Hansen; A Gitomirsky
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

7.  Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound.

Authors:  T G John; J D Greig; J L Crosbie; W F Miles; O J Garden
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

8.  Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome.

Authors:  P Hildebrand; T Leibecke; M Kleemann; L Mirow; M Birth; H P Bruch; C Bürk
Journal:  Eur J Surg Oncol       Date:  2006-03-07       Impact factor: 4.424

9.  Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution.

Authors:  Ronnie T Poon; Kelvin K Ng; Chi Ming Lam; Victor Ai; Jimmy Yuen; Sheung Tat Fan; John Wong
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

10.  Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  R Santambrogio; M Podda; M Zuin; E Bertolini; S Bruno; G P Cornalba; M Costa; M Montorsi
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

View more
  4 in total

1.  History, ethics, advantages and limitations of experimental models for hepatic ablation.

Authors:  Seok Ling Ong; Gianpiero Gravante; Matthew S Metcalfe; Ashley R Dennison
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

2.  Porcine ex vivo liver phantom for dynamic contrast-enhanced computed tomography: development and initial results.

Authors:  Scott M Thompson; Juan C Ramirez-Giraldo; Bruce Knudsen; Joseph P Grande; Jodie A Christner; Man Xu; David A Woodrum; Cynthia H McCollough; Matthew R Callstrom
Journal:  Invest Radiol       Date:  2011-09       Impact factor: 6.016

3.  Synthesis and characterisation of a cancerous liver for presurgical planning and training applications.

Authors:  Richard Arm; Arash Shahidi; Christopher Clarke; Edward Alabraba
Journal:  BMJ Open Gastroenterol       Date:  2022-07

4.  Design and development of adapters for electromagnetic trackers to perform navigated laparoscopic radiofrequency ablation.

Authors:  Philipp Hildebrand; Armin Besirevic; Markus Kleemann; Stefan Schlichting; Volker Martens; Achim Schweikard; Hans-Peter Bruch
Journal:  Ann Surg Innov Res       Date:  2007-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.